These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 7060025
1. Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine. Boehm TL, Drahovsky D. Cancer Res; 1982 Apr; 42(4):1537-40. PubMed ID: 7060025 [Abstract] [Full Text] [Related]
2. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine. Kong XB, Tong WP, Chou TC. Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001 [Abstract] [Full Text] [Related]
3. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells. Walsh CT, Craig RW, Agarwal RP. Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943 [Abstract] [Full Text] [Related]
4. Elevated transcriptional complexity and decrease in enzymatic DNA methylation in cells treated with L-ethionine. Boehm TL, Drahovsky D. Cancer Res; 1981 Oct; 41(10):4101-6. PubMed ID: 6169431 [Abstract] [Full Text] [Related]
10. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P, Lien EJ, Avramis VI. Anticancer Res; 1999 Oct; 19(3A):1625-33. PubMed ID: 10470093 [Abstract] [Full Text] [Related]
12. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells. Maehara Y, Kusumoto T, Sakaguchi Y, Kusumoto H, Anai H, Sugimachi K. Anticancer Res; 1989 Oct; 9(1):41-4. PubMed ID: 2705754 [Abstract] [Full Text] [Related]
13. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH. Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808 [Abstract] [Full Text] [Related]
14. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD. Oncol Res; 1994 Nov 15; 6(2):87-99. PubMed ID: 7949469 [Abstract] [Full Text] [Related]
18. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor. Fietkau R, Friede H, Maurer-Schultze B. Cancer Res; 1984 Mar 15; 44(3):1105-13. PubMed ID: 6692397 [Abstract] [Full Text] [Related]
19. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Abe I, Saito S, Hori K, Suzuki M, Sato H. Cancer Res; 1982 Jul 15; 42(7):2846-51. PubMed ID: 7083175 [Abstract] [Full Text] [Related]
20. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells. Tsuruo T, Iida H, Hori K, Tsukagoshi S, Sakurai Y. Cancer Res; 1981 Nov 15; 41(11 Pt 1):4484-8. PubMed ID: 7306971 [Abstract] [Full Text] [Related] Page: [Next] [New Search]